OCT-based diagnosis, management, and predictors of recurrent stent failure: a cohort study.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-05-13 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1565676
Giacomo Maria Cioffi, Pablo Lamelas, Mariam Shenouda, Jamie Halperin, Francesca Goffredo, Brian Patrick McGrath, Norman Said Vega Servin, Shamir R Mehta, Sanjit S Jolly, J D Schwalm, Madhu K Natarajan, Nicholas Valettas, James L Velianou, Michael B Tsang, Natalia Pinilla-Echeverri, Matthew G Sibbald, Tej N Sheth
{"title":"OCT-based diagnosis, management, and predictors of recurrent stent failure: a cohort study.","authors":"Giacomo Maria Cioffi, Pablo Lamelas, Mariam Shenouda, Jamie Halperin, Francesca Goffredo, Brian Patrick McGrath, Norman Said Vega Servin, Shamir R Mehta, Sanjit S Jolly, J D Schwalm, Madhu K Natarajan, Nicholas Valettas, James L Velianou, Michael B Tsang, Natalia Pinilla-Echeverri, Matthew G Sibbald, Tej N Sheth","doi":"10.3389/fcvm.2025.1565676","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Stent failure (SF) is a complication of percutaneous coronary intervention (PCI).</p><p><strong>Objectives: </strong>This study aimed to assess the relationship of the optical coherence tomography (OCT) determined cause of SF with time since stent implantation, treatment, and outcome.</p><p><strong>Methods: </strong>This retrospective study included patients who underwent an OCT evaluation for SF from January 2013 to July 2023. In-stent findings were evaluated on OCT including tissue proliferation, tissue type, underexpansion, thrombus, and multiple stent layers. The relationship between time to presentation, treatment, and outcome was assessed.</p><p><strong>Results: </strong>Of the 309 patients who underwent an OCT-guided PCI for SF, tissue proliferation was present in 228 (74%) and absent in 81 (26%). Among patients with tissue proliferation, OCT commonly showed lipidic neointima (<i>n</i> = 122, 54%), thrombus (<i>n</i> = 81, 36%), and underexpansion (<i>n</i> = 71, 31%). In patients without tissue proliferation, OCT commonly identified underexpansion (<i>n</i> = 58, 72%), thrombus (<i>n</i> = 55, 68%), and uncovered struts (<i>n</i> = 37, 46%). The mean time to SF was 6.89 ± 5.88 years with tissue proliferation and 2.98 ± 3.75 years without (<i>p</i> < 0.001). Patients with tissue proliferation were more likely to be treated with repeat stenting (78% vs. 60%, <i>p</i> < 0.001). Lipidic neointimal tissue and >1 layer of stent were predictors of target SF recurrence during a median 3 years of follow-up.</p><p><strong>Conclusion: </strong>In a large series of OCT-guided treatments of SF, tissue proliferation was more common, occurred later after stent implantation, and was more likely to be treated with repeat stenting than no-tissue proliferation. Lipidic neointimal tissue and >1 layer of stent were significant predictors of target SF during follow-up.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1565676"},"PeriodicalIF":2.8000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12106419/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1565676","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Stent failure (SF) is a complication of percutaneous coronary intervention (PCI).

Objectives: This study aimed to assess the relationship of the optical coherence tomography (OCT) determined cause of SF with time since stent implantation, treatment, and outcome.

Methods: This retrospective study included patients who underwent an OCT evaluation for SF from January 2013 to July 2023. In-stent findings were evaluated on OCT including tissue proliferation, tissue type, underexpansion, thrombus, and multiple stent layers. The relationship between time to presentation, treatment, and outcome was assessed.

Results: Of the 309 patients who underwent an OCT-guided PCI for SF, tissue proliferation was present in 228 (74%) and absent in 81 (26%). Among patients with tissue proliferation, OCT commonly showed lipidic neointima (n = 122, 54%), thrombus (n = 81, 36%), and underexpansion (n = 71, 31%). In patients without tissue proliferation, OCT commonly identified underexpansion (n = 58, 72%), thrombus (n = 55, 68%), and uncovered struts (n = 37, 46%). The mean time to SF was 6.89 ± 5.88 years with tissue proliferation and 2.98 ± 3.75 years without (p < 0.001). Patients with tissue proliferation were more likely to be treated with repeat stenting (78% vs. 60%, p < 0.001). Lipidic neointimal tissue and >1 layer of stent were predictors of target SF recurrence during a median 3 years of follow-up.

Conclusion: In a large series of OCT-guided treatments of SF, tissue proliferation was more common, occurred later after stent implantation, and was more likely to be treated with repeat stenting than no-tissue proliferation. Lipidic neointimal tissue and >1 layer of stent were significant predictors of target SF during follow-up.

基于oct的支架失效复发的诊断、管理和预测因素:一项队列研究。
背景:支架失效(SF)是经皮冠状动脉介入治疗(PCI)的并发症。目的:本研究旨在评估光学相干断层扫描(OCT)确定的SF病因与支架植入时间、治疗和预后的关系。方法:本回顾性研究纳入了2013年1月至2023年7月期间接受SF OCT评估的患者。在OCT上评估支架内的发现,包括组织增生、组织类型、扩张不足、血栓和支架多层。评估就诊时间、治疗和结果之间的关系。结果:在309例接受oct引导的SF PCI治疗的患者中,有228例(74%)出现组织增殖,81例(26%)没有组织增殖。在组织增生的患者中,OCT通常显示脂质新生内膜(n = 122, 54%)、血栓(n = 81, 36%)和扩张不足(n = 71, 31%)。在没有组织增生的患者中,OCT通常发现扩张不足(n = 58, 72%)、血栓(n = 55, 68%)和未覆盖的支撑(n = 37, 46%)。在中位3年随访期间,有组织增生的SF的平均时间为6.89±5.88年,无1层支架的SF的平均时间为2.98±3.75年,这是SF复发的预测指标。结论:在大量oct引导下的SF治疗中,组织增生更为常见,且发生在支架植入术后较晚,且较无组织增生更容易重复支架植入术。脂质内膜组织和支架bbb1层是随访中靶SF的重要预测因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信